Nachrichten zu Telix Pharmaceuticals

Startseite > Aktien > Telix Pharmaceuticals > Nachrichten

Telix Pharmaceuticals Aktie

Aktie

ISIN: AU000000TLX2 WKN: A2H7JK SYM: T3X Land Flagge AU

Australien

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

11,790

EUR

+6,41 %

+0,710 EUR

Letzter Kurs 14:30:10 Tradegate

Geldkurs

16:12:24

11,575

EUR

266 STK

Briefkurs

16:12:24

11,790

EUR

256 STK

Telix Pharmaceuticals Aktie kaufen

Kauf

Verkauf

Neueste Nachrichten

‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology 11.09.24 · globenewswire · Telix Pharmaceuticals
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 04.09.24 · globenewswire · Telix Pharmaceuticals
Telix Submits NDA for TLX101-CDx (Pixclara) Brain Cancer Imaging Agent 28.08.24 · globenewswire · Telix Pharmaceuticals
Telix Announces Reorganisation to Deliver on Strategic Priorities 27.08.24 · globenewswire · Telix Pharmaceuticals
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 22.08.24 · globenewswire · Telix Pharmaceuticals
Expanded Access Program Opens in the U.S. for TLX101-CDx, Telix’s Investigational Glioma (Brain Cancer) Imaging Agent 29.07.24 · globenewswire · Telix Pharmaceuticals
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 24.07.24 · globenewswire · Telix Pharmaceuticals
Q2 2024 Revenue and Business Highlights, Guidance Upgrade 18.07.24 · globenewswire · Telix Pharmaceuticals
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals 11.07.24 · globenewswire · Telix Pharmaceuticals
wO Börsenlounge : Cavendish \| Adidas \| Evotec & Short-Squeeze bei Super Micro Computer im Anflug? 20.06.24 · Markus Weingran · Evotec
Telix Announces Launch of Proposed Initial Public Offering in the United States 05.06.24 · globenewswire · Telix Pharmaceuticals
Telix Completes TLX250-CDx (Zircaix) BLA Submission for Kidney Cancer Imaging 03.06.24 · globenewswire · Telix Pharmaceuticals

1
2
…
3

‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology 508 Leser

Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 740 Leser
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology 508 Leser
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 452 Leser
Telix Announces Reorganisation to Deliver on Strategic Priorities 448 Leser
Telix Submits NDA for TLX101-CDx (Pixclara) Brain Cancer Imaging Agent 444 Leser

wO Börsenlounge : Gamestop \| HealWELL AI \| Merck & die 10 Top und Flop KI-Aktien der Hedgefonds 25004 Leser
wO Börsenlounge : Cavendish \| Adidas \| Evotec & Short-Squeeze bei Super Micro Computer im Anflug? 9792 Leser
wO Börsenlounge : Barrick Gold \| Telix \| Fresenius - Intel eifert Nvidia nach! 7732 Leser
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities 740 Leser
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology 508 Leser
Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline 492 Leser
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances 452 Leser
Telix Announces Reorganisation to Deliver on Strategic Priorities 448 Leser
Telix Submits NDA for TLX101-CDx (Pixclara) Brain Cancer Imaging Agent 444 Leser
Telix Announces Planned Registered Public Offering and Listing in the United States 348 Leser